eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 21/11/2011
PIL Haldol 2mg/ml oral liquid

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 26/05/2011 and displayed until 21/11/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 17/02/2010 and displayed until 26/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/08/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 06/04/2009 and displayed until 10/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 22/12/2008 and displayed until 06/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 01/09/2008 and displayed until 22/12/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 30/07/2008 and displayed until 01/09/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 28/06/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 03/04/2007 and displayed until 28/06/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 13/02/2007 and displayed until 03/04/2007
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 22/09/2006 and displayed until 13/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 10/03/2006 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 28/02/2006 and displayed until 10/03/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
Updated on 09/06/2005 and displayed until 28/02/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/05/2005 and displayed until 09/06/2005
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change of manufacturer
  • Change to date of revision
Updated on 09/04/2001 and displayed until 31/05/2005
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   haloperidol